vendredi 18 avril 2014


A lire sur:

Manufacturing is a key source of innovation and competitiveness in Europe. However, increasing competition and the rapid progress of technological development create a constant need for companies to evolve and adopt new production methods.

Based on the needs expressed by the local industry, the main theme of Business meets Research 2014 will be "Manufacturing of the Future".

Workshops and pitching sessions featuring researchers and experts from Luxembourg and the Greater Region:
Additive Manufacturing
Robotisation of small lot size production
Environmental sustainability of manufacturing

Why participate?

Improve the productivity and performance of your company
Develop innovative products and services
Meet partners for R&D and innovation projects

Innovation Matchmaking

Bilateral face-to-face meetings with representatives of companies and public research laboratories.

Open for Business: from Research to Reality at Manchester University

The University of Manchester is now the UK’s largest single-site University with a total annual income of £802M, of which £270M is derived from external research funding. The University is committed to ensuring that this substantial research effort yields economic and social benefit wherever possible and its strategy and policies encourage its academic staff to embrace entrepreneurship as a worthy and legitimate academic pursuit. Dr Rich Ferrie will show how Manchester has developed a unique systematic process and infrastructure dedicated to this agenda which has yielded over 50 new companies and 340 technology licenses since 2004. Opportunities for investors, entrepreneurs and management to engage with Manchester will be explored.


Dr Rich Ferrie, Director of Operations at The University of Manchester Intellectual Property (UMIP), UK

Dr Ferrie is Director of Operations at UMIP – the technology transfer Division of UMI3  Ltd. In this role he leads a group of 27 people responsible for identifying, protecting and commercialising intellectual property arising from the University of Manchester. UMIP has a strong record of IP commercialisation which has resulted in a number of high profile companies and licensing deals with major international companies. Previously, he spent 11 years in various scientific and commercial roles with the diagnostics business of AstraZeneca culminating with leadership of its Sales and Marketing function internationally.  A Biochemistry graduate (Sussex), Dr Ferrie gained a PhD in Molecular Biology from the University of Reading. After a short period of post-doctoral research with the UK Forensic Science Service, he continued his work developing DNA fingerprinting technology at ICI Diagnostics. In 1991, Dr Ferrie was appointed Technology Development Manager and is an inventor on 4 international patent applications. This work enabled the development of the first commercial cystic fibrosis genetic testing product. Dr Ferrie then took a senior BD role developing commercial collaborations and relationships with businesses internationally. From 1998 he established and led the Sales and Marketing department of Zeneca Diagnostics and was responsible for the ELUCIGENETM  product range.

Aucun commentaire:

Enregistrer un commentaire